Pharmacokinetics and Exposure-Response Analysis of RG7667, a Combination of Two Anti-Cytomegalovirus Monoclonal Antibodies, in a Phase 2a Randomized Trial to Prevent Cytomegalovirus Infection in High-Risk Kidney Transplant Recipients

Antimicrobial Agents and Chemotherapy - United States
doi 10.1128/aac.01108-17
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Society for Microbiology


Related search